Fundamental pharmacokinetic behavior of sulfadimethoxine, sulfamethoxazole and their biotransformed products in dogs.
- 1 January 1981
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 29 (12) , 3741-3747
- https://doi.org/10.1248/cpb.29.3741
Abstract
Plasma concentration profiles of sulfadimethoxine, sulfamethoxazole [antiinfective drugs] and their biotransformed products (N4-acetate and N1-glucuronide) in dogs were determined and their pharmacokinetic parameters were calculated by using a 2-compartment open model. The apparent partition coefficients between chloroform and phosphate buffer were also determined. Decline in plasma levels of sulfadimethoxine and sulfamethoxazole was considerably accelerated by N4-acetylation and N1-glucuronidation. The elimination of sulfadimethoxine-N1-glucuronide from plasma was more rapid than that of sulfadimethoxine-N4-acetate, and a similar tendency was observed for sulfamethoxazole and its biotransformed products. N4-Acetylation or N1-glucuronidation of sulfadimethoxine and sulfamethoxazole decreased the lipid solubilities markedly in comparison with those of original sulfonamides.This publication has 3 references indexed in Scilit:
- Shortcomings in Pharmacokinetic Analysis by Conceiving the Body to Exhibit Properties of a Single CompartmentJournal of Pharmaceutical Sciences, 1968
- Studies on the Metabolism of Sulfadimethoxine. III. Kinetics of Sulfadimethoxine Metabolism.CHEMICAL & PHARMACEUTICAL BULLETIN, 1967
- The structure of the glucuronide of sulphadimethoxine formed in manBiochemical Journal, 1965